Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

MRVIMRVI
23 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in MARAVAI LIFESCIENCES HLDGSA

Yes. Citadel Advisors holds 2,122,598 shares of MRVI (Maravai Lifesciences Hldgsa), worth $13.2M, as of its Q2 2026 13F filing. It increased the position by 638,279 shares (+43.0%) from Q1 2026. Citadel Advisors has held MRVI since Q4 2024, across 7 quarterly 13F filings.

Current Value

$13.2M

Current Shares

2.1M

Total Value Change

-$19.7M

Total Shares Change

+949,069

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.1M
+43.0%
$13.2M0.0%$6.24
38
2026-Q1
Increased
1.5M
+140.4%
$4.2M0.0%$2.83
43
2025-Q4
Increased
617,454
+594.9%
$2M0.0%$3.25
42
2025-Q3
Decreased
88,854
-85.4%
$255,0110.0%$2.87
0
2025-Q2
Decreased
608,738
-43.0%
$1.5M0.0%$2.41
0
2025-Q1
Increased
1.1M
+4997.0%
$2.4M0.0%$2.21
42
2024-Q4
New
20,969
-
$114,2810.0%$5.45
34
2024-Q3
Exited
0
-100.0%
$00.0%$8.31
0
2024-Q2
Increased
357,549
+32.4%
$2.6M0.0%$7.16
33
2024-Q1
Decreased
270,163
-76.4%
$2.3M0.0%$8.67
0
2023-Q4
Decreased
1.1M
-35.0%
$7.5M0.0%$6.55
0
2023-Q3
Increased
1.8M
+107x
$17.6M0.0%$10.00
46
2023-Q2
Decreased
16,356
-96.9%
$203,3050.0%$12.43
0
2023-Q1
Increased
520,557
+4.9%
$7.3M0.0%$14.01
29
2022-Q4
Decreased
496,282
-72.8%
$7.1M0.0%$14.31
0
2022-Q3
Increased
1.8M
+1239.2%
$46.6M0.0%$25.53
47
2022-Q2
Decreased
136,209
-68.7%
$3.9M0.0%$28.41
0
2022-Q1
Increased
434,891
+75.8%
$15.3M0.0%$35.27
43
2021-Q4
Decreased
247,303
-81.2%
$10.4M0.0%$41.90
0
2021-Q3
Increased
1.3M
+99.1%
$64.7M0.0%$49.08
48
2021-Q2
Increased
661,713
+106.4%
$27.6M0.0%$41.73
46
2021-Q1
Decreased
320,538
-72.7%
$11.4M0.0%$35.64
0
2020-Q4
New
1.2M
-
$32.9M0.0%$28.05
40

Other major holders of MRVI: FMR LLC, Select Equity Group, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used